Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03305497 · ClinicalTrials.gov registry record
Piloting a Naloxone Intervention in Philadelphia
A clinical trial, sponsored by Drexel University.
- Completed
- Registry status
- 110
- Enrollment target
NCT03305497 is a clinical trial that has completed, run by Drexel University. The registered enrollment target is 110 participants.
The verdict
NCT03305497 has completed, sponsored by Drexel University.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
The escalating opioid overdose epidemic is one of the most serious public health problems confronting the U.S. Death due to drug overdose is a significant and rising cause of mortality and morbidity in Philadelphia. While naloxone is increasingly accessible to combat opioid overdoses, new responses to delivering naloxone to overdose events are needed. The proposed pilot project, to be conducted in Philadelphia, will pursue three specific aims: 1) Identify barriers and facilitators of acceptance and use of a smartphone-based naloxone intervention; 2) Pilot test the implementation of the intervention among 55 non-medical opioid users and 55 community members; 3) Synthesize knowledge acquired in Aims 1 and 2 to be used in a subsequent R01 study to conduct a large-scale, multi-site implementation trial.
Interventions
- BEHAVIORAL Mobile Phone Application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2018-10-23 |
| Est. Completion | 2021-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03305497
The ClinicalTrials.gov registry entry for NCT03305497 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Drexel University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mobile Phone Application is the first listed.
NCT03305497 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03305497 about?
NCT03305497 is a clinical study titled "Piloting a Naloxone Intervention in Philadelphia". The escalating opioid overdose epidemic is one of the most serious public health problems confronting the U.S. Death due to drug overdose is a significant and rising cause of mortality and morbidity in Philadelphia. While naloxone is increasingly accessible to combat opioid overdoses, new responses ...
What is the current status of trial NCT03305497?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2018-10-23. Estimated completion is 2021-05-31.
What interventions are being tested in trial NCT03305497?
The interventions under investigation include: Mobile Phone Application (BEHAVIORAL).
Who is sponsoring clinical trial NCT03305497?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.